CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,577,126
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,577,126. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-26 | MOTT DAVID M 10% owner | Sale | −1,460,209 | $0.50 | $731K | 0 |
| 2018-02-26 | MAKOWER JOSHUA 10% owner | Sale | −1,460,209 | $0.50 | $731K | 0 |
| 2018-02-26 | Florence Anthony A. Jr. 10% owner | Sale | −1,460,209 | $0.50 | $731K | 0 |
| 2018-02-26 | BASKETT FOREST 10% owner | Sale | −1,460,209 | $0.50 | $731K | 0 |
| 2018-02-26 | BARRIS PETER J 10% owner | Sale | −1,460,209 | $0.50 | $731K | 0 |
| 2018-02-26 | Growth Equity Opportunities IV, LLC 10% owner | Sale | −1,460,209 | $0.50 | $731K | 0 |
| 2017-07-14 | CONWAY ROBERT E Director | Purchase | +10,000 | $2.49 | $25K | 35,000 |
| 2017-05-02 | MITCHELL DANIEL J Director | Purchase | +11,000 | $2.71 | $30K | 11,000 |
| 2017-04-04 | Ozeroff Christopher David S.V.P., General Counsel | Sale | −418 | $2.41 | $1K | 17,517 |
| 2017-04-04 | Keuer Thomas A Chief Operating Officer | Sale | −390 | $2.41 | $940 | 14,045 |
| 2017-04-04 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Sale | −720 | $2.41 | $2K | 41,155 |
| 2017-04-03 | Selby Brian L. VP, Finance | Sale | −1,114 | $2.46 | $3K | 1,275 |
| 2017-03-24 | CONWAY ROBERT E Director | Purchase | +25,000 | $2.59 | $65K | 25,000 |
| 2017-02-28 | Ozeroff Christopher David S.V.P., General Counsel | Sale | −465 | $2.61 | $1K | 17,935 |
| 2017-02-28 | Keuer Thomas A Chief Operating Officer | Sale | −465 | $2.61 | $1K | 14,435 |
| 2017-02-28 | BRISTOW MICHAEL R Pres. & Chief Executive Offic | Sale | −763 | $2.61 | $2K | 41,875 |
| 2017-02-27 | Selby Brian L. VP, Finance | Sale | −161 | $2.56 | $412 | 2,389 |
| 2017-02-27 | Selby Brian L. VP, Finance | Grant or award · Stock Option (right to buy) | +24,100 | 24,100 | ||
| 2017-02-27 | Ozeroff Christopher David S.V.P., General Counsel | Grant or award · Stock Option (right to buy) | +22,700 | 22,700 | ||
| 2017-02-27 | Keuer Thomas A Chief Operating Officer | Grant or award · Stock Option (right to buy) | +23,800 | 23,800 |
Page 21 of 24 · 473 trades